Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates.
Dendrimers have emerged as promising multifunctional nanomaterials for drug delivery due to their well-defined size and tailorability. We compare two schemes to obtain methylprednisolone (MP)-polyamidoamine dendrimer (PAMAM-G4-OH) conjugate. Glutaric acid (GA) was used as a spacer to facilitate the conjugation. In scheme A, PAMAM-G4-OH was first coupled to GA and then further conjugated with MP to obtain PAMAM-G4-GA-MP conjugates. This scheme yields a lower conjugation ratio of MP, presumably because of lower reactivity and steric hindrance for the steroid at the crowded dendrimer periphery. In scheme B, this steric hindrance was overcome by first preparing the MP-GA conjugate, which was then coupled to the PAMAM-G4-OH dendrimer. The (1)H NMR spectrum of the conjugate from scheme B indicates a conjugation of 12 molecules of MP with the dendrimer, corresponding to a payload of 32 wt %. In addition, conjugates were further fluorescent-labeled with fluoroisothiocynate (FITC) to evaluate the dynamics of cellular entry. Flow cytometry and UV/visible spectroscopic analysis showed that the conjugate is rapidly taken up inside the cell. Fluorescence and confocal microscopy images on A549 human lung epithelial carcinoma cells treated with conjugates show that the conjugate is mostly localized in cytosol. MP-GA-dendrimer conjugate showed comparable pharmacological activity to free MP, as measured by inhibition of prostaglandin secretion. These conjugates can potentially be further conjugated with a targeting moiety to deliver the drugs to specific cells in vivo.
Khandare
Jayant
J
Department of Chemical Engineering and Material Science, and Biomedical Engineering, Wayne State University, Detroit, Michigan 48202, USA.
Kolhe
Parag
P
Pillai
Omathanu
O
Kannan
Sujatha
S
Lieh-Lai
Mary
M
Kannan
Rangaramanujam M
RM
D001692:Biological Transport; D045744:Cell Line, Tumor; D002463:Cell Membrane Permeability; D003432:Cross-Linking Reagents; D003600:Cytosol / Q000378:metabolism; D016503:Drug Delivery Systems; D016650:Fluorescein-5-isothiocyanate; D006801:Humans; D046911:Macromolecular Substances; D009682:Magnetic Resonance Spectroscopy; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D009757:Nylons / Q000493:pharmacokinetics; D011453:Prostaglandins / Q000378:metabolism
D003432:Cross-Linking Reagents; D046911:Macromolecular Substances; D009757:Nylons; D011453:Prostaglandins; D016650:Fluorescein-5-isothiocyanate; D008775:Methylprednisolone